Stable pergolide mesylate and process for making same
AssigneeTeva Pharmaceuticals Industries, Ltd.
InventorsRuth Tenengauzer, Minutza Leibovici
Life of this patent
Estimating the term…
Abstract
A formulation and a method for manufacturing pergolide mesylate is disclosed whereby substantially stable pergolide mesylate can be manufactured without having to introduce stabilizing additives.
Claims22
A method for manufacturing pergolide mesylate resistant to degradation when exposed to light, the method comprising:
- forming a powder mixture having lactose monohydrate, microcrystalline cellulose, pregelatinized starch, sodium starch, glycolate;
- dissolving pergolide mesylate in water and alcohol to form a pergolide mesylate solution;
- forming a wet granulation by adding the pergolide mesylate solution to the powder mixture;
- drying the wet granulation to form dry granulate;
- milling the dry granulate to form milled granulate;
- mixing magnesium stearate with milled granulate to form a blend.
A method for manufacturing pergolide mesylate which is resistant to degradation, the method comprising:
- forming a powder mixture having pergolide mesylate, lactose monohydrate, microcrystalline cellulose, pregelatinized starch, sodium starch glycolate, color ferric oxide and magnesium stearate;
- compressing the powder mixture into at least one tablet;
- milling the at least one tablet to form a powder;
- and
- mixing the milled powder with magnesium stearate to produce stable pergolide mesylate.
The method of step 7, further comprising compressing the stable pergolide mesylate into tablets.
A method for manufacturing pergolide mesylate in the absence of a stabilizing agent, the method comprising:
- providing a powder mixture having at least one of lactose monohydrate, microcrystalline cellulose, pregelatinized starch, sodium starch, glycolate;
- forming a solution of pergolide mesylate in water and alcohol to form a pergolide mesylate solution;
- forming a wet granulation by adding the pergolide mesylate solution to the powder mixture;
- drying the wet granulation to form dry granulate;
- milling the dry granulate to form milled granulate;
- mixing magnesium stearate with milled granulate to form a blend.
A method for manufacturing pergolide mesylate composition which is resistant to degradation, the method comprising:
- forming a powder mixture having pergolide mesylate, at least one filler, at least one disintegrant and at least one lubricant;
- compressing the powder mixture into at least one tablet;
- milling the at least one tablet to form a powder;
- mixing the milled powder with magnesium stearate to produce stable pergolide mesylate;
- wherein the pergolide mesylate composition initially contains less than 0.5 wt. % pergolide sulfoxide and after three months of storage at 40° C. and 75% relative humidity contains less than 2.4 wt. % pergolide sulfoxide.
A method for manufacturing pergolide mesylate composition which is resistant to degradation, the method comprising:
- forming a powder mixture having pergolide mesylate, at least one filler selected from the group consisting of lactose monohydrate, at least one disintegrant selected from the group consisting of pregelatinized starch and sodium starch glycolate, and at least one binder;
- compressing the powder mixture into at least one tablet;
- milling the at least one tablet to form a powder;
- and
- mixing the milled powder with magnesium stearate to produce stable pergolide mesylate.
A method for manufacturing pergolide mesylate oral dosage which is resistant to degradation, the method comprising:
- forming a powder mixture having pergolide mesylate and at least one additive selected from the group consisting of a filler, a binder, a diluent and a disintegrant;
- wherein the oral dosage initially contains less than 0.5 wt. % pergolide sulfoxide and after three months of storage at 40° C. and 75% relative humidity contains less than 2.4 wt. % pergolide sulfoxide.
Dependencies are inferred from the claim text.